Login to Your Account

Cubist Gains FDA Approval Of Cubicin For Skin Infections

By Kim Coghill

Tuesday, September 16, 2003
The FDA approved Cubist Pharmaceuticals Inc.'s first-in-class antibiotic, Cubicin, for infections caused by Gram-positive bacteria. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription